psoriasis

Shah M, DeBusk L, Bohman MH, Rosenberg A, Burshtein J, Zakria D, Armstrong A, Boh E, Gottlieb AB, Khattri S, Litchman G, Merola J, Murina[...]

By afschroeder • July 29, 2026

Zakria D, Shah M, Rosenberg A, Burshtein J, DeBusk L, Altman DA, Armstrong AW, Gottlieb AB, Han G, Khattri S, Shaigany S, Weinberg JM, Lebwohl[...]

By afschroeder • July 29, 2026

DeBusk L, Bartley B, Armstrong AW, Bunick CG, Del Rosso J, Desai SR, Eichenfield LF, Elewski BE, Golant AK, Issa N, Stein Gold L, Swanson[...]

By afschroeder • July 29, 2026

Madsen N, Coates LC, Merola JF, Ho W, Hsueh W, Kiltz U, Ranganath VK, Deodhar A, Troum OM, Diaz C, Kronbergs A, Bello N, Mease[...]

By afschroeder • July 16, 2026

Hendrie AG, Hadj Smaine L. Pemigatinib-Associated Psoriasis in a Patient With Cholangiocarcinoma. Cureus. 2026 May 7;18(5):e108439. doi: 10.7759/cureus.108439. PMID: 42255868; PMCID: PMC13242240.

By afschroeder • June 9, 2026

Maul JT, Fröhlich F, Nielsen ML, Maul LV, Torres T, Thyssen J, Armstrong A, Oon HH, Ji M, Kang X, Valenzuela F, Romiti R, Carvalho[...]

By afschroeder • May 20, 2026

Elbuluk N, Armstrong AW, Vender R, Bhutani T, Green L, Ferris LK, Laquer V, Moore A, Weisman J, Zhang W, Winkelman W, Gooderham MJ. Zasocitinib[...]

By afschroeder • May 17, 2026

Armstrong AW, Krueger JG, Strober BE, Stein Gold LF, Desai SR, Muscianisi E, Klyachkin Y, Ucpinar S, Tilley MK, Blauvelt A. Envudeucitinib, a Potent, Next-Generation,[...]

By afschroeder • April 5, 2026

Ma EJ, Roberts AM, Jeong CY, Chou P, Katz A, Nong Y, Johnsen N, Yan M, Ochoa MT, Armstrong AW. GLP-1RAs and cardiovascular risk reduction[...]

By afschroeder • March 7, 2026

Roberts AM, Jeong C, Chou P, Ma EJ, Katz A, Yan MJ, Johnsen N, Nong Y, Armstrong AW. Association between out-of-pocket costs and treatment patterns[...]

By afschroeder • January 22, 2026